Article Information
History
- September 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Margherita Vieri1,2,*,
- Vithurithra Tharmapalan2,3,4,*,
- Milena Kalmer1,2,
- Julian Baumeister1,2,
- Miloš Nikolić2,3,4,
- Matthis Schnitker2,3,4,
- Martin Kirschner1,2,
- Niclas Flosdorf3,5,
- Marcelo A. S. de Toledo1,2,
- Martin Zenke1,2,3,5,
- Steffen Koschmieder1,2,
- Tim H. Brümmendorf1,2,*,
- Fabian Beier1,2,* and
- Wolfgang Wagner2,3,4,#,*
- 1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074 Aachen, Germany
- 2Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD)
- 3Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074 Aachen, Germany
- 4Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, 52074 Aachen, Germany
- 5Institute for Biomedical Engineering – Cell Biology, Medical Faculty of RWTH Aachen University, 52074 Aachen, Germany
- ↵#Corresponding author: Wolfgang Wagner, Helmholtz-Institute for Biomedical Engineering, Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, Pauwelsstrasse 20, Aachen, Germany, Phone: +49 241 8088611; E-mail: wwagner{at}ukaachen.de
↵* These authors contributed equally to this work
Posted September 12, 2023.
Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms
